Antitrust Lawyer Blog

Commentary on Current Developments

Also on July 14, several parties asked the FCC to deny license transfers related to the proposed sale of Verizon Communications, Inc.'s (“Verizon”) Puerto Rico telecom assets – including the incumbent local exchange carrier and its second largest wireless service operator – to America Movil S.A. de C.V. (“American Movil”). Competitors are concerned that the new operators will block the development of competition, regulators in Puerto Rico are dubious of the proposed deal's public-interest claims, and law enforcement officials want more time to examine national security and other questions.

The Telecommunications Regulatory Board of Puerto Rico petitioned the FCC to deny the license-transfer petition, under which Verizon would sell its interest in Telecommunicaciones de Puerto Rico, Inc., which is the parent of Puerto Rico Telephone Co. (“PRTC”) and PRT Larga Distancia, Inc., among other subsidiaries. In particular, the board raised concerns about how the transaction would affect service quality and was also unimpressed with pledges to “examine” wireless network upgrades, adding that competition and demand make such a “purported 'benefit' inevitable, no matter who controls PRTC.”

In addition, it dismissed claims of economies of scale that would be created by the transaction, doubting that America Movil would benefit from economies of scale not enjoyed by Verizon. “The application offers a public interest statement that is nothing but meaningless platitudes, devoid of specifics, tangible benefits, and real commitments,” the board said. It also said the transaction would create a “direct adverse effect” by giving America Movil its substantial asset in a U.S. jurisdiction, which would be a “magnet for litigation” and would put the “assets of the Puerto Rico Telephone Company in jeopardy.”

On July 14, a federal judge said he wants to examine internal FCC documents regarding two large recent telephone company mergers to see if the Justice Department protected market competition in approving the buyouts. U.S. District Court Judge Emmet G. Sullivan’s review concerns the now-completed mergers of SBC Communications Inc. (“SBC”) with AT&T Corp. (“AT&T”) and Verizon Communications Inc. (“Verizon”) with MCI Inc. (“MCI”).

The court’s opinion could possibly establish tougher obstacles for future mergers such as the proposed $67 billion buyout of BellSouth Corp. by AT&T Inc. – the name SBC adopted after completing the purchase of AT&T. Required by Congress, the court review calls for a judge to approve any agreement reached between the government and a company allowing a merger to proceed. The judge needs to decide if agreed-upon conditions such as selling certain assets adequately address concerns about lost competition.

In the order signed on July 14, Sullivan wrote that the Federal Communications Commission had agreed to provide unedited versions of the agency’s merger orders and opinions. The order also said the FCC’s deputy general counsel, P. Michele Ellison, was seeking consent from all individuals and entities who provided confidential information contained in the FCC documents. The FCC and the DOJ approved the two deals late last year, requiring modest divestitures of certain overlapping assets and market commitments such as not requiring customers to buy phone service in order to get high-speed Internet access.

On July 13, the FCC approved the sale of substantially all of the cable systems and assets of Adelphia Communications Corporation (“Adelphia”) to Time Warner Inc. (“Time Warner”) and Comcast Corporation (“Comcast”), the exchange of certain cable systems and assets between affiliates or subsidiaries of Time Warner and Comcast, and the redemption of Comcast's interests in Time Warner Cable and Time Warner Entertainment Company.

In reaching its decision, the FCC found that the transactions, as conditioned, serve the public interest and comply with all applicable statutes and Commission rules. The Commission also found that the potential public interest harms of the transactions, as conditioned, are outweighed by the potential public interest benefits. With respect to benefits, the Commission determined that subscribers would benefit from the resolution of the Adelphia bankruptcy proceeding in the form of new investment and upgrades to the network.

Additionally, the transactions would accelerate deployment of VoIP and other advanced video services, such as local VOD programming, to subscribers. With respect to the potential harms, the Commission found that the proposed transactions may increase the likelihood of harm in markets in which Time Warner or Comcast has, or may in the future have, an ownership interest in Regional Sports Networks (“RSNs”). The Commission imposed remedial conditions, the same as those imposed in the News Corp.-Hughes order to address its concerns.

On July 13, 2006, the European Court of First Instance (“CFI”) reversed a July 18, 2004 decision by the European Commission allowing a merger between music groups Sony and BMG.

This decision was reached in the wake of an application made by the Independent Music Publishers and Labels Association (“Impala”), an international association representing the interests of 2,500 independent music production companies, on December 3, 2004, after the Commission reversed an earlier decision stating that a combination would increase concentration and was incompatible with European Community law.

The CFI said that the Commission did not sufficiently demonstrate either the non-existence of a collective dominant position before the concentration, or the absence of a risk that such a position would be created as a result of the concentration. Furthermore, the court criticized the Commission for executing an extremely superficial investigation of whether the two companies could achieve a collective dominant position through the merger.

On July 11, Smith & Nephew's Endoscopy division acquired San Antonio-based OsteoBiologics Inc. Smith & Nephew officials say they will pay $72.3 million in cash for OBI, which is a private company. OBI sells bioabsorbable bone graft substitutes in Europe to repair cartilage defects in the knee, and offers the substances in the United States that are used to strengthen bones. The company reported sales revenue in 2005 of $3.3 million. Smith & Nephew is a worldwide seller of medical devices in endoscopy, orthopedic reconstruction, and advanced wound management.

Authored by

Robert W. Doyle, Jr.

On July 10, the Federal Trade Commission and the Department of Justice's Antitrust Division announced that the third in a series of planned joint public hearings designed to examine the antitrust implications of single-firm conduct under the antitrust laws will take place on July 18, 2006, in Washington, DC. As previously announced, these public hearings will examine whether and when specific types of single-firm conduct may violate Section 2 of the Sherman Act by harming competition and consumer welfare and when they are pro-competitive or benign.

The hearings will continue through the year. The session on July 18, which will be held at 601 New Jersey Ave., N.W., Washington, DC, Conference Room C, and will go from 1:30 to 5:00 pm, will focus on the competitive implications associated with unilateral refusals to deal. Such refusals occur when a firm chooses not to make a product or service available to another firm.

The session's participants will be:

On July 7, the Federal Trade Commission (“FTC”) challenged Hologic Inc.’s 2005 purchase of Fischer Imaging Corporation’s breast cancer screening and diagnosis business. Hologic closed its $32 million transaction without reporting it to the FTC because Hologic’s acquisition of Fischer’s assets was not reportable under the Hart-Scott-Rodino Premerger Notification Act (“HSR Act”), as it was valued at less than the current $56.7 million filing threshold. Accordingly, the FTC did not have an opportunity to investigate the deal before the parties consummated the transaction.

In its complaint, the FTC alleged that Hologic’s acquisition of Fischer’s prone stereotactic breast biopsy systems (“SBBSs”) business harmed consumers by eliminating its only significant competitor for the sale of SBBSs in the United States. To settle the charges, Hologic is required to sell the Fischer prone SBBS assets to Siemens AG, a leader in the business of medical imaging.

The challenge serves as a powerful reminder that the mere fact that a deal is not HSR reportable does not mean that the transaction has been approved by the FTC or cleared from a potential challenge.

On July 7, the Federal Trade Commission announced its decision to challenge Hologic Inc.'s 2005 purchase of the breast cancer screening and diagnosis business of Fischer Imaging Corporation. In its complaint, the FTC alleged that Hologic's acquisition of Fischer's prone stereotactic breast biopsy systems (“SBBSs”) business harmed American consumers by eliminating its only significant competitor for the sale of SBBSs in the United States.

In settling the Commission's charges, Hologic is required to sell the Fischer prone SBBS assets to Siemens AG, a leader in the business of medical imaging. “Left unchallenged, Hologic's purchase from Fischer would have deprived American women of the benefits of competition for these critical healthcare services,” said Jeffrey Schmidt, Director of the FTC's Bureau of Competition. “The Commission's action today ensures that these essential services will be provided at lower prices and higher quality.”

On September 29, 2005, Hologic paid $32 million to acquire all of Fischer's intellectual property and other assets related to its mammography and breast biopsy businesses, including patents, trademarks, and customer and vendor lists for Fischer's prone SBBS product, MammoTest. At the time, Fischer was Hologic's only significant competitor in the U.S. market for prone SBBSs. As a result of the acquisition, Fischer relinquished all of its rights to develop, market, and sell prone SBBSs in the United States. This left Hologic with a virtual monopoly in the U.S. prone SBBS market. Hologic's acquisition of Fischer's assets was not reportable under the Hart-Scott-Rodino Premerger Notification Act as it was valued at less than the $56.7 million filing threshold.

An operation that sold bogus college financial aid services was permanently banned on July 6 from selling academic goods or services for repeatedly violating court orders. The Federal Trade Commission (“FTC”) originally charged that the defendants promised better college financial aid packages than someone could find on their own, which they did not deliver.

Settlement of those charges barred the defendants from making deceptive claims and the defendants then violated the order by continuing their deceptive marketing practices. The judge found the defendants in contempt and ordered them to provide refunds to consumers. The FTC charged the defendants with contempt for a second time for failing to provide those refunds.

In 2003, the FTC accused Integrated Capital, Inc., doing business as National Student Financial Aid, and its owner Alan Wilson, of misrepresenting that if consumers bought certain academic goods and services that they would be more likely to get college financial aid than they would on their own. The court order to settle those charges prohibited them from misrepresenting information about academic goods or services and required the company and its officers to make certain disclosures when selling their products.

Contact Information